Medivation

August 23, 2016
Pfizer to Buy Medivation for $14 Billion, But Who Are the Real Winners?

Pfizer to Buy Medivation for $14 Billion, But Who Are the Real Winners?

Pharmaceutical giants Pfizer are expanding their cancer portfolio through the $14B acquisition of California-based biopharmaceutical company Medivation. The acquisition follows two recent unsuccessful bids for Medivation […]
Contact Us